WEL Substance Profile
Hexavalent Chromium — Workplace Exposure Limit Change
CAS: 18540-29-9 | Notation: Inhalable fraction, carcinogen (IARC Group 1)
Current WES
0.05
mg/m³
New WEL (Dec 2026)
0.005
mg/m³
Change
-90%
reduction
Health Effects
Hexavalent chromium is classified as a Group 1 carcinogen by IARC, meaning there is sufficient evidence that it causes cancer in humans. The primary cancer risk is lung cancer, with studies demonstrating significantly elevated rates among chromate production workers, chromium platers, and stainless steel welders. Beyond carcinogenicity, hexavalent chromium causes severe respiratory effects including nasal septum perforation, chronic rhinitis, and occupational asthma. Skin contact produces characteristic chrome ulcers and allergic contact dermatitis. Kidney damage has been documented in workers with chronic exposure. The genotoxic mechanism of hexavalent chromium means there is no true safe threshold — the WEL represents an acceptable risk level rather than a no-effect level.
Where Exposure Occurs
What to Do Now
Monitoring Method
Personal air sampling using a calibrated pump with 37mm mixed cellulose ester filter in a closed-face cassette. Analysis by ion chromatography (IC) following NIOSH Method 7605 for hexavalent chromium speciation. Sampling should cover a full shift with a flow rate of 2 L/min. Results must be reported as hexavalent chromium, not total chromium.
Affected Industries
Measure exposure against the right limit
OH Consultant designs and runs personal exposure monitoring for chromium, reviewed by a Certified Industrial Hygienist, and reports results against the limit that applies to your site, whether the 1 December 2026 WHS WEL or a mine-specific limit.
Request a sampling proposal